W. Anthony Vernon's most recent trade in NovoCure Ltd was a trade of 16,697 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 4, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| NovoCure Ltd | W. Anthony Vernon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 16,697 | 16,697 | - | - | Stock Option (Right to Buy) | |
| NovoCure Ltd | W. Anthony Vernon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 11,215 | 179,102 (0%) | 0% | 0 | Ordinary Shares | |
| NovoCure Ltd | W. Anthony Vernon | Director | Sale of securities on an exchange or to another person at price $ 17.35 per share. | 03 Jun 2025 | 999 | 167,887 (0%) | 0% | 17.3 | 17,329 | Ordinary Shares |
| Nuvation Bio Inc - Ordinar... | W. Anthony Vernon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2025 | 292,983 | 292,983 | - | - | Stock Option (Right to Buy) | |
| McCormick & Company | W. Anthony Vernon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2025 | 1,344 | 11,826 (0%) | 0% | 0 | Common Stock - Voting | |
| McCormick & Company | W. Anthony Vernon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2025 | 1,344 | 0 | - | - | Restricted Stock Units | |
| McCormick & Company | W. Anthony Vernon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2025 | 2,222 | 2,222 | - | - | Restricted Stock Units | |
| Nuvation Bio Inc - Ordinar... | W. Anthony Vernon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Sep 2024 | 200,801 | 200,801 | - | - | Stock Option (Right to Buy) | |
| NovoCure Ltd | W. Anthony Vernon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 6,229 | 6,229 | - | - | Stock Option (Right to Buy) | |
| NovoCure Ltd | W. Anthony Vernon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 4,053 | 169,850 | - | 0 | Restricted Stock Units | |
| NovoCure Ltd | W. Anthony Vernon | Director | Sale of securities on an exchange or to another person at price $ 23.89 per share. | 04 Jun 2024 | 964 | 164,833 (0%) | 0% | 23.9 | 23,033 | Ordinary Shares |
| McCormick & Company | W. Anthony Vernon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2024 | 3,732 | 3,732 | - | - | Options - Right to Buy | |
| McCormick & Company | W. Anthony Vernon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2024 | 1,344 | 1,344 | - | - | Restricted Stock Units | |
| McCormick & Company | W. Anthony Vernon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 1,255 | 10,482 (0%) | 0% | - | Common Stock - Voting | |
| McCormick & Company | W. Anthony Vernon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 1,255 | 0 | - | - | Restricted Stock Units | |
| NovoCure Ltd | W. Anthony Vernon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 6,277 | 6,277 | - | - | Stock Option (Right to Buy) | |
| NovoCure Ltd | W. Anthony Vernon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 3,853 | 165,797 | - | 0 | Restricted Stock Units | |
| Nuvation Bio Inc - Ordinar... | W. Anthony Vernon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2023 | 366,744 | 366,744 | - | - | Stock Option (Right to Buy) | |
| McCormick & Company | W. Anthony Vernon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 3,101 | 3,101 | - | - | Options- Right to Buy | |
| McCormick & Company | W. Anthony Vernon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 1,255 | 1,255 | - | - | Restricted Stock Units | |
| McCormick & Company | W. Anthony Vernon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2023 | 1,044 | 0 | - | - | Restricted Stock Units | |
| McCormick & Company | W. Anthony Vernon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2023 | 1,044 | 9,227 (0%) | 0% | 0 | Common Stock - Voting | |
| NovoCure Ltd | W. Anthony Vernon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 8,700 | 8,700 | - | - | Options to Buy Ordinary Shares | |
| Nuvation Bio Inc - Ordinar... | W. Anthony Vernon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2022 | 140,713 | 140,713 | - | - | Stock Option (Right to Buy) | |
| McCormick & Company | W. Anthony Vernon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2022 | 2,711 | 2,711 | - | - | Options- Right to Buy | |
| McCormick & Company | W. Anthony Vernon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2022 | 1,044 | 1,044 | - | - | Restricted Stock Units | |
| McCormick & Company | W. Anthony Vernon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2022 | 1,139 | 8,183 (0%) | 0% | - | Common Stock - Voting | |
| McCormick & Company | W. Anthony Vernon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2022 | 1,139 | 0 | - | - | Restricted Stock Units | |
| NovoCure Ltd | W. Anthony Vernon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2021 | 1,499 | 1,499 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | W. Anthony Vernon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2021 | 814 | 161,944 | - | 0 | Restricted Stock Units | |
| McCormick & Company | W. Anthony Vernon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2021 | 3,268 | 3,268 | - | - | Options - Right to Buy | |
| McCormick & Company | W. Anthony Vernon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2021 | 1,156 | 1,156 | - | - | Restricted Stock Units | |
| McCormick & Company | W. Anthony Vernon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2021 | 1,468 | 7,044 (0%) | 0% | - | Common Stock - Voting | |
| McCormick & Company | W. Anthony Vernon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2021 | 1,468 | 0 | - | - | Restricted Stock Units |